10-Q Filing

AGILON HEALTH, INC. CIK: 1831097 Q3 2021

Filing Information

Form Type	10-Q
Accession Number	`0000950170-21-002473`
Period End Date	20210930
Filing Date	20211028
Fiscal Year	2021
Fiscal Period	Q3
XBRL Instance	agl-20210930_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 73 Income Statement 89 Cash Flow Statement 74 Stockholders Equity 39

Balance Sheet 73 line items

Line Item	Tag	Value	Unit	Period
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.08B	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$106.80M	USD	Point-in-time
Restricted cash and equivalents	`RestrictedCashEquivalentsCurrent`	$28.38M	USD	Point-in-time
Restricted cash and equivalents	`RestrictedCashEquivalentsCurrent`	$14.30M	USD	Point-in-time
Receivables, net	`ReceivablesNetCurrent`	$342.50M	USD	Point-in-time
Receivables, net	`ReceivablesNetCurrent`	$144.56M	USD	Point-in-time
Prepaid expenses and other current assets, net	`PrepaidExpenseAndOtherAssetsCurrent`	$9.64M	USD	Point-in-time
Prepaid expenses and other current assets, net	`PrepaidExpenseAndOtherAssetsCurrent`	$14.46M	USD	Point-in-time
Redeemable common stock, par value	`TemporaryEquityParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Current assets held for sale and discontinued operations, net	`AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent`	$4.83M	USD	Point-in-time
Redeemable common stock, shares issued	`TemporaryEquitySharesIssued`	76.20M	shares	Point-in-time
Redeemable common stock, outstanding	`TemporaryEquitySharesOutstanding`	76.20M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$294.20M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$1.45B	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$6.46M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$6.46M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	2.00B	shares	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$58.15M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	2.00B	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	2.00B	shares	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$60.47M	USD	Point-in-time
Goodwill	`Goodwill`	$41.54M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	391.55M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	249.37M	shares	Point-in-time
Goodwill	`Goodwill`	$41.54M	USD	Point-in-time
Other assets, net	`OtherAssetsNoncurrent`	$126.11M	USD	Point-in-time
Other assets, net	`OtherAssetsNoncurrent`	$43.70M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	249.37M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	391.55M	shares	Point-in-time
Total assets	`Assets`	$446.36M	USD	Point-in-time
Assets	`Assets`	$446.36M	USD	Point-in-time
Total assets	`Assets`	$1.69B	USD	Point-in-time
Assets	`Assets`	$1.69B	USD	Point-in-time
Liabilities	`Liabilities`	$421.59M	USD	Point-in-time
Liabilities	`Liabilities`	$557.68M	USD	Point-in-time
Medical claims and related payables	`LiabilityForClaimsAndClaimsAdjustmentExpense`	$288.12M	USD	Point-in-time
Medical claims and related payables	`LiabilityForClaimsAndClaimsAdjustmentExpense`	$162.87M	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$129.66M	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$97.24M	USD	Point-in-time
Current portion of long-term debt	`LongTermDebtCurrent`	$5.00M	USD	Point-in-time
Current portion of long-term debt	`LongTermDebtCurrent`	$3.04M	USD	Point-in-time
Current liabilities held for sale and discontinued operations	`LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent`	$3.68M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$422.78M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$266.83M	USD	Point-in-time
Long-term debt, net of current portion	`LongTermDebtNoncurrent`	$64.67M	USD	Point-in-time
Long-term debt, net of current portion	`LongTermDebtNoncurrent`	$44.63M	USD	Point-in-time
Other liabilities	`OtherLiabilitiesNoncurrent`	$90.27M	USD	Point-in-time
Other liabilities	`OtherLiabilitiesNoncurrent`	$90.09M	USD	Point-in-time
Total liabilities	`Liabilities`	$421.59M	USD	Point-in-time
Total liabilities	`Liabilities`	$557.68M	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Contingently redeemable common stock, $0.01 par value: 76,201 shares issued and outstanding at December 31, 2020	`TemporaryEquityCarryingAmountAttributableToParent`	$309.50M	USD	Point-in-time
Common stock, $0.01 par value: 2,000,000 shares authorized; 391,548 and 249,374 shares issued and outstanding, respectively	`CommonStockValue`	$3.92M	USD	Point-in-time
Common stock, $0.01 par value: 2,000,000 shares authorized; 391,548 and 249,374 shares issued and outstanding, respectively	`CommonStockValue`	$2.49M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$263.97M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$2.02B	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-551.19M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-900.96M	USD	Point-in-time
Total agilon health, inc. stockholders' equity (deficit)	`StockholdersEquity`	$1.13B	USD	Point-in-time
Total agilon health, inc. stockholders' equity (deficit)	`StockholdersEquity`	$-284.73M	USD	Point-in-time
Noncontrolling interests	`MinorityInterest`	$-284.00K	USD	Point-in-time
Total stockholders equity (deficit)	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-262.29M	USD	Point-in-time
Total stockholders equity (deficit)	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-248.28M	USD	Point-in-time
Total stockholders equity (deficit)	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.13B	USD	Point-in-time
Total stockholders equity (deficit)	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.15B	USD	Point-in-time
Total stockholders equity (deficit)	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-232.03M	USD	Point-in-time
Total stockholders equity (deficit)	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-284.73M	USD	Point-in-time
Total liabilities, contingently redeemable common stock and stockholders equity (deficit)	`LiabilitiesAndStockholdersEquity`	$1.69B	USD	Point-in-time
Total liabilities, contingently redeemable common stock and stockholders equity (deficit)	`LiabilitiesAndStockholdersEquity`	$446.36M	USD	Point-in-time

Income Statement 89 line items

Line Item	Tag	Value	Unit	Period
Medical service revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$312.68M	USD	1 Quarter
Medical service revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$1.37B	USD	3 Qtrs
Medical service revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$458.61M	USD	1 Quarter
Medical service revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$897.33M	USD	3 Qtrs
Medical services expense	`PolicyholderBenefitsAndClaimsIncurredHealthCare`	$260.93M	USD	1 Quarter
Medical services expense	`PolicyholderBenefitsAndClaimsIncurredHealthCare`	$1.22B	USD	3 Qtrs
Medical services expense	`PolicyholderBenefitsAndClaimsIncurredHealthCare`	$414.20M	USD	1 Quarter
Medical services expense	`PolicyholderBenefitsAndClaimsIncurredHealthCare`	$728.95M	USD	3 Qtrs
Other medical expenses	`OtherMedicalExpenses`	$79.51M	USD	3 Qtrs
Other medical expenses	`OtherMedicalExpenses`	$29.45M	USD	1 Quarter
Other medical expenses	`OtherMedicalExpenses`	$26.32M	USD	1 Quarter
Other medical expenses	`OtherMedicalExpenses`	$86.81M	USD	3 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$30.37M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$114.00M	USD	3 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$91.20M	USD	3 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$34.68M	USD	1 Quarter
Stock-based compensation expense	`AllocatedShareBasedCompensationExpense`	$4.73M	USD	3 Qtrs
Stock-based compensation expense	`AllocatedShareBasedCompensationExpense`	$287.98M	USD	3 Qtrs
Stock-based compensation expense	`AllocatedShareBasedCompensationExpense`	$2.60M	USD	Point-in-time
Stock-based compensation expense	`AllocatedShareBasedCompensationExpense`	$11.96M	USD	1 Quarter
Stock-based compensation expense	`AllocatedShareBasedCompensationExpense`	$1.56M	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$3.92M	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$3.34M	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$10.92M	USD	3 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$9.86M	USD	3 Qtrs
Total expenses	`OperatingExpenses`	$322.53M	USD	1 Quarter
Total expenses	`OperatingExpenses`	$914.26M	USD	3 Qtrs
Total expenses	`OperatingExpenses`	$1.72B	USD	3 Qtrs
Total expenses	`OperatingExpenses`	$494.21M	USD	1 Quarter
Income (loss) from operations	`OperatingIncomeLoss`	$-346.08M	USD	3 Qtrs
Income (loss) from operations	`OperatingIncomeLoss`	$-16.93M	USD	3 Qtrs
Income (loss) from operations	`OperatingIncomeLoss`	$-9.84M	USD	1 Quarter
Income (loss) from operations	`OperatingIncomeLoss`	$-35.60M	USD	1 Quarter
Other income (expense), net	`NonoperatingIncomeExpense`	$-421.00K	USD	3 Qtrs
Other income (expense), net	`NonoperatingIncomeExpense`	$4.03M	USD	3 Qtrs
Other income (expense), net	`NonoperatingIncomeExpense`	$-269.00K	USD	1 Quarter
Other income (expense), net	`NonoperatingIncomeExpense`	$-469.00K	USD	1 Quarter
Interest expense	`InterestExpense`	$1.95M	USD	1 Quarter
Interest expense	`InterestExpense`	$867.00K	USD	1 Quarter
Interest expense	`InterestExpense`	$5.31M	USD	3 Qtrs
Interest expense	`InterestExpense`	$6.18M	USD	3 Qtrs
Income (loss) before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-347.35M	USD	3 Qtrs
Income (loss) before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-12.27M	USD	1 Quarter
Income (loss) before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-36.74M	USD	1 Quarter
Income (loss) before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-23.53M	USD	3 Qtrs
Income tax benefit (expense)	`IncomeTaxExpenseBenefit`	$74.00K	USD	3 Qtrs
Income tax benefit (expense)	`IncomeTaxExpenseBenefit`	$707.00K	USD	3 Qtrs
Income tax benefit (expense)	`IncomeTaxExpenseBenefit`	$256.00K	USD	1 Quarter
Income tax benefit (expense)	`IncomeTaxExpenseBenefit`	$35.00K	USD	1 Quarter
Income (loss) from continuing operations	`IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest`	$-36.99M	USD	1 Quarter
Income (loss) from continuing operations	`IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest`	$-12.30M	USD	1 Quarter
Income (loss) from continuing operations	`IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest`	$-23.61M	USD	3 Qtrs
Income (loss) from continuing operations	`IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest`	$-348.06M	USD	3 Qtrs
Income (loss) before income taxes	`DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax`	$584.00K	USD	1 Quarter
Income (loss) before income taxes	`DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax`	$-1.78M	USD	3 Qtrs
Income (loss) before income taxes	`DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax`	$1.12M	USD	1 Quarter
Income (loss) before income taxes	`DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax`	$-11.85M	USD	3 Qtrs
Income tax benefit (expense)	`DiscontinuedOperationTaxEffectOfDiscontinuedOperation`	$82.00K	USD	1 Quarter
Income tax benefit (expense)	`DiscontinuedOperationTaxEffectOfDiscontinuedOperation`	$385.00K	USD	3 Qtrs
Income tax benefit (expense)	`DiscontinuedOperationTaxEffectOfDiscontinuedOperation`	$211.00K	USD	3 Qtrs
Income tax benefit (expense)	`DiscontinuedOperationTaxEffectOfDiscontinuedOperation`	$110.00K	USD	1 Quarter
Total discontinued operations	`IncomeLossFromDiscontinuedOperationsNetOfTax`	$-12.23M	USD	3 Qtrs
Total discontinued operations	`IncomeLossFromDiscontinuedOperationsNetOfTax`	$474.00K	USD	1 Quarter
Total discontinued operations	`IncomeLossFromDiscontinuedOperationsNetOfTax`	$1.03M	USD	1 Quarter
Total discontinued operations	`IncomeLossFromDiscontinuedOperationsNetOfTax`	$-1.99M	USD	3 Qtrs
Net income (loss)	`ProfitLoss`	$-35.96M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$-350.05M	USD	3 Qtrs
Net income (loss)	`ProfitLoss`	$-11.83M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$-35.84M	USD	3 Qtrs
Noncontrolling interests' share in (earnings) loss	`NetIncomeLossAttributableToNoncontrollingInterest`	-	USD	1 Quarter
Noncontrolling interests' share in (earnings) loss	`NetIncomeLossAttributableToNoncontrollingInterest`	-	USD	3 Qtrs
Noncontrolling interests' share in (earnings) loss	`NetIncomeLossAttributableToNoncontrollingInterest`	$-115.00K	USD	1 Quarter
Noncontrolling interests' share in (earnings) loss	`NetIncomeLossAttributableToNoncontrollingInterest`	$-284.00K	USD	3 Qtrs
Net income (loss) attributable to common shares	`NetIncomeLoss`	$-349.77M	USD	3 Qtrs
Net income (loss) attributable to common shares	`NetIncomeLoss`	$-35.84M	USD	1 Quarter
Net income (loss) attributable to common shares	`NetIncomeLoss`	$-11.83M	USD	1 Quarter
Net income (loss) attributable to common shares	`NetIncomeLoss`	$-35.84M	USD	3 Qtrs
Continuing operations	`IncomeLossFromContinuingOperationsPerBasicAndDilutedShare`	$-0.95	USD	3 Qtrs
Continuing operations	`IncomeLossFromContinuingOperationsPerBasicAndDilutedShare`	$-0.04	USD	1 Quarter
Continuing operations	`IncomeLossFromContinuingOperationsPerBasicAndDilutedShare`	$-0.09	USD	1 Quarter
Continuing operations	`IncomeLossFromContinuingOperationsPerBasicAndDilutedShare`	$-0.07	USD	3 Qtrs
Discontinued operations	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare`	$-0.04	USD	3 Qtrs
Discontinued operations	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare`	$-0.01	USD	3 Qtrs
Discontinued operations	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare`	-	USD	1 Quarter
Discontinued operations	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare`	-	USD	1 Quarter
Weighted average shares outstanding, basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	391.23M	shares	1 Quarter
Weighted average shares outstanding, basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	324.07M	shares	3 Qtrs
Weighted average shares outstanding, basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	324.56M	shares	1 Quarter
Weighted average shares outstanding, basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	365.02M	shares	3 Qtrs

Cash Flow Statement 74 line items

Line Item	Tag	Value	Unit	Period
Net income (loss)	`ProfitLoss`	$-35.96M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$-350.05M	USD	3 Qtrs
Net income (loss)	`ProfitLoss`	$-11.83M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$-35.84M	USD	3 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$10.35M	USD	3 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$11.03M	USD	3 Qtrs
Stock-based compensation expense	`ShareBasedCompensation`	$4.92M	USD	3 Qtrs
Stock-based compensation expense	`ShareBasedCompensation`	$287.98M	USD	3 Qtrs
Loss on debt extinguishment	`GainsLossesOnExtinguishmentOfDebt`	$-1.59M	USD	3 Qtrs
Loss on debt extinguishment	`GainsLossesOnExtinguishmentOfDebt`	-	USD	3 Qtrs
Loss (Income) from equity method investments	`IncomeLossFromEquityMethodInvestments`	$2.08M	USD	3 Qtrs
Loss (Income) from equity method investments	`IncomeLossFromEquityMethodInvestments`	$33.00K	USD	3 Qtrs
Release of indemnification assets	`FDICIndemnificationAssetNetWriteOffs`	-	USD	3 Qtrs
Release of indemnification assets	`FDICIndemnificationAssetNetWriteOffs`	$-280.00K	USD	3 Qtrs
Other noncash items	`OtherNoncashIncomeExpense`	$111.00K	USD	3 Qtrs
Other noncash items	`OtherNoncashIncomeExpense`	$276.00K	USD	3 Qtrs
Changes in operating assets and liabilities	`IncreaseDecreaseInOperatingCapital`	$19.26M	USD	3 Qtrs
Changes in operating assets and liabilities	`IncreaseDecreaseInOperatingCapital`	$47.62M	USD	3 Qtrs
Net cash provided by (used in) operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-99.26M	USD	3 Qtrs
Net cash provided by (used in) operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-39.87M	USD	3 Qtrs
Purchase of property and equipment, net	`PaymentsToAcquirePropertyPlantAndEquipment`	$3.16M	USD	3 Qtrs
Purchase of property and equipment, net	`PaymentsToAcquirePropertyPlantAndEquipment`	$1.26M	USD	3 Qtrs
Purchase of intangible assets	`PaymentsToAcquireIntangibleAssets`	$6.79M	USD	3 Qtrs
Purchase of intangible assets	`PaymentsToAcquireIntangibleAssets`	$533.00K	USD	3 Qtrs
Investment in loans receivable and other	`PaymentsToAcquireLoansReceivable`	$76.61M	USD	3 Qtrs
Investment in loans receivable and other	`PaymentsToAcquireLoansReceivable`	$2.31M	USD	3 Qtrs
Proceeds from repayment of loans receivable	`ProceedsFromCollectionOfLoansReceivable`	$1.31M	USD	3 Qtrs
Proceeds from repayment of loans receivable	`ProceedsFromCollectionOfLoansReceivable`	$1.06M	USD	3 Qtrs
Proceeds from sale of business and property, net of cash divested	`ProceedsFromDivestitureOfBusinessesNetOfCashDivested`	$1.82M	USD	3 Qtrs
Proceeds from sale of business and property, net of cash divested	`ProceedsFromDivestitureOfBusinessesNetOfCashDivested`	$-2.64M	USD	3 Qtrs
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-1.21M	USD	3 Qtrs
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-87.90M	USD	3 Qtrs
Proceeds from initial public offering	`ProceedsFromIssuanceInitialPublicOffering`	-	USD	3 Qtrs
Proceeds from initial public offering	`ProceedsFromIssuanceInitialPublicOffering`	$1.17B	USD	3 Qtrs
Proceeds from other equity issuances, net	`ProceedsFromIssuanceOfCommonStock`	$33.59M	USD	3 Qtrs
Proceeds from other equity issuances, net	`ProceedsFromIssuanceOfCommonStock`	-	USD	3 Qtrs
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	$1.61M	USD	3 Qtrs
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	$814.00K	USD	3 Qtrs
Repurchase of shares, net	`PaymentsForRepurchaseOfEquity`	-	USD	3 Qtrs
Repurchase of shares, net	`PaymentsForRepurchaseOfEquity`	$6.74M	USD	3 Qtrs
Proceeds from the issuance of long-term debt	`ProceedsFromIssuanceOfLongTermDebt`	-	USD	3 Qtrs
Proceeds from the issuance of long-term debt	`ProceedsFromIssuanceOfLongTermDebt`	$100.00M	USD	3 Qtrs
Equity and debt issuance costs and other	`PaymentOfFinancingAndStockIssuanceCosts`	$9.93M	USD	3 Qtrs
Equity and debt issuance costs and other	`PaymentOfFinancingAndStockIssuanceCosts`	-	USD	3 Qtrs
Repayments of long-term borrowings and other	`RepaymentsOfLongTermDebt`	$2.28M	USD	3 Qtrs
Repayments of long-term borrowings and other	`RepaymentsOfLongTermDebt`	$118.65M	USD	3 Qtrs
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$25.38M	USD	3 Qtrs
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$1.14B	USD	3 Qtrs
Net increase (decrease) in cash, cash equivalents and restricted cash and equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$-15.69M	USD	3 Qtrs
Net increase (decrease) in cash, cash equivalents and restricted cash and equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$956.81M	USD	3 Qtrs
Cash, cash equivalents and restricted cash and equivalents from continuing operations, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$135.18M	USD	Point-in-time
Cash, cash equivalents and restricted cash and equivalents from continuing operations, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.10B	USD	Point-in-time
Cash, cash equivalents and restricted cash and equivalents from continuing operations, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$126.49M	USD	Point-in-time
Cash, cash equivalents and restricted cash and equivalents from continuing operations, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$139.15M	USD	Point-in-time
Cash, cash equivalents and restricted cash and equivalents from discontinued operations, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations`	-	USD	Point-in-time
Cash, cash equivalents and restricted cash and equivalents from discontinued operations, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations`	$6.46M	USD	Point-in-time
Cash, cash equivalents and restricted cash and equivalents from discontinued operations, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations`	$3.92M	USD	Point-in-time
Cash, cash equivalents and restricted cash and equivalents from discontinued operations, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations`	$3.43M	USD	Point-in-time
Cash, cash equivalents and restricted cash and equivalents, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$129.92M	USD	Point-in-time
Cash, cash equivalents and restricted cash and equivalents, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$145.61M	USD	Point-in-time
Cash, cash equivalents and restricted cash and equivalents, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$139.09M	USD	Point-in-time
Cash, cash equivalents and restricted cash and equivalents, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$1.10B	USD	Point-in-time
Cash, cash equivalents and restricted cash and equivalents from continuing operations, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$135.18M	USD	Point-in-time
Cash, cash equivalents and restricted cash and equivalents from continuing operations, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.10B	USD	Point-in-time
Cash, cash equivalents and restricted cash and equivalents from continuing operations, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$126.49M	USD	Point-in-time
Cash, cash equivalents and restricted cash and equivalents from continuing operations, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$139.15M	USD	Point-in-time
Cash, cash equivalents and restricted cash and equivalents from discontinued operations, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations`	-	USD	Point-in-time
Cash, cash equivalents and restricted cash and equivalents from discontinued operations, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations`	$6.46M	USD	Point-in-time
Cash, cash equivalents and restricted cash and equivalents from discontinued operations, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations`	$3.92M	USD	Point-in-time
Cash, cash equivalents and restricted cash and equivalents from discontinued operations, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations`	$3.43M	USD	Point-in-time
Cash, cash equivalents and restricted cash and equivalents, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$129.92M	USD	Point-in-time
Cash, cash equivalents and restricted cash and equivalents, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$145.61M	USD	Point-in-time
Cash, cash equivalents and restricted cash and equivalents, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$139.09M	USD	Point-in-time
Cash, cash equivalents and restricted cash and equivalents, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$1.10B	USD	Point-in-time

Stockholders Equity 39 line items

Line Item	Tag	Value	Unit	Period
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-262.29M	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-248.28M	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.13B	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.15B	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-232.03M	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-284.73M	USD	Point-in-time
Contingently Redeemable Common Stock, Beginning balance, shares	`TemporaryEquitySharesOutstanding`	76.20M	shares	Point-in-time
Contingently Redeemable Common Stock, Beginning balance	`TemporaryEquityCarryingAmountAttributableToParent`	$309.50M	USD	Point-in-time
Beginning balance, shares	`CommonStockSharesOutstanding`	249.37M	shares	Point-in-time
Beginning balance, shares	`CommonStockSharesOutstanding`	391.55M	shares	Point-in-time
Net income (loss)	`ProfitLoss`	$-35.96M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$-350.05M	USD	3 Qtrs
Net income (loss)	`ProfitLoss`	$-11.83M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$-35.84M	USD	3 Qtrs
Issuance of contingently redeemable common stock	`IssuanceOfContingentlyRedeemableCommonStockValue`	$-460.00K	USD	3 Qtrs
Issuance of common stock, net	`StockIssuedDuringPeriodValueNewIssues`	$951.00K	USD	1 Quarter
Issuance of common stock, net	`StockIssuedDuringPeriodValueNewIssues`	$5.55M	USD	3 Qtrs
Repurchase of common stock	`StockRepurchasedDuringPeriodValue`	$6.74M	USD	1 Quarter
Repurchase of common stock	`StockRepurchasedDuringPeriodValue`	$6.74M	USD	3 Qtrs
Exercise of stock options and other, net	`StockIssuedDuringPeriodValueStockOptionsExercised`	$814.00K	USD	3 Qtrs
Exercise of stock options and other, net	`StockIssuedDuringPeriodValueStockOptionsExercised`	$1.61M	USD	3 Qtrs
Exercise of stock options and other, net	`StockIssuedDuringPeriodValueStockOptionsExercised`	$1.05M	USD	1 Quarter
Exercise of stock options and other, net	`StockIssuedDuringPeriodValueStockOptionsExercised`	$497.00K	USD	1 Quarter
Settlement of stock-based liabilities	`AdjustmentsToAdditionalPaidInCapitalSettlementOfStockBasedLiabilities`	$1.50M	USD	1 Quarter
Settlement of stock-based liabilities	`AdjustmentsToAdditionalPaidInCapitalSettlementOfStockBasedLiabilities`	$1.50M	USD	3 Qtrs
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$1.62M	USD	1 Quarter
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$4.92M	USD	3 Qtrs
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$19.51M	USD	3 Qtrs
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$11.96M	USD	1 Quarter
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-262.29M	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-248.28M	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.13B	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.15B	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-232.03M	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-284.73M	USD	Point-in-time
Contingently Redeemable Common Stock, Ending balance, shares	`TemporaryEquitySharesOutstanding`	76.20M	shares	Point-in-time
Contingently Redeemable Common Stock, Ending balance	`TemporaryEquityCarryingAmountAttributableToParent`	$309.50M	USD	Point-in-time
Ending balance, shares	`CommonStockSharesOutstanding`	249.37M	shares	Point-in-time
Ending balance, shares	`CommonStockSharesOutstanding`	391.55M	shares	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.